TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Genus plc ( (GB:GNS) ) has issued an update.
Genus plc has announced the appointment of Dr. Celia Baxter and Dr. Robert Reiter as Non-Executive Directors, effective November 19, 2025, and January 1, 2026, respectively. Dr. Baxter brings extensive experience in human resources and strategic management, while Dr. Reiter offers significant expertise in genetics and gene editing technology. These appointments are expected to enhance Genus’s strategic and scientific capabilities, potentially strengthening its position in the animal genetics industry.
The most recent analyst rating on (GB:GNS) stock is a Hold with a £2646.00 price target. To see the full list of analyst forecasts on Genus plc stock, see the GB:GNS Stock Forecast page.
Spark’s Take on GB:GNS Stock
According to Spark, TipRanks’ AI Analyst, GB:GNS is a Neutral.
Genus plc’s overall stock score is driven by strong financial performance and operational efficiency. However, high valuation and neutral technical indicators suggest caution. The lack of earnings call and corporate events data limits further insights.
To see Spark’s full report on GB:GNS stock, click here.
More about Genus plc
Genus plc is a world-leading animal genetics company that advances animal breeding and genetic improvement through biotechnology. It provides added value products for livestock farming and food producers, focusing on dairy, beef, and pork food production sectors. Genus operates globally in over seventy-five countries under the trademarks ‘ABS’ for dairy and beef cattle and ‘PIC’ for pigs, offering superior genetics through semen, embryos, and breeding animals.
Average Trading Volume: 143,552
Technical Sentiment Signal: Buy
Current Market Cap: £1.62B
See more insights into GNS stock on TipRanks’ Stock Analysis page.